{"schema_version":"secwatch.filing_event.v1","accession":"0001801170-25-000269","form_type":"8-K","ticker":"CLOV","cik":"0001801170","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","filed_at":"2025-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.499481+00:00","generated_at":"2026-05-17T00:40:54.500997+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Clover Health Q3 revenue up 50% YoY to $497M, but cuts FY25 adjusted EBITDA guidance to $15M-$30M","bullets":["Q3 GAAP net loss $24.4M; revenue $496.7M vs $331M YoY; membership 109,226 (+35% YoY).","Adjusted EBITDA Q3 $2.1M; YTD $45M; FY guidance cut to $15M-$30M from prior $50M-$70M.","Insurance BER Q3 93.5%; full-year BER guidance raised to 90%-91% from 88.5%-89.5%.","Revised FY25 insurance revenue guidance up to $1.850B-$1.880B; midpoint +39% YoY.","Management cites new member mix and elevated utilization; sees 2026 tailwinds from 4-star payment and CMS rate."],"urls":{"canonical":"https://secwatch.observer/filing/0001801170-25-000269","json":"https://secwatch.observer/filing/0001801170-25-000269.json","markdown":"https://secwatch.observer/filing/0001801170-25-000269.md","text":"https://secwatch.observer/filing/0001801170-25-000269.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000269/0001801170-25-000269-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1801170/000180117025000269/clov-20251104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:40:54.500997+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}